Difficulty: Medium
Average Score: 81%
Practice
A healthcare provider is caring for a client who has a new prescription for Digoxin. Which of the following findings should the healthcare provider identify as a potential sign of Digoxin toxicity?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Nausea as a potential sign of Digoxin toxicity. Digoxin is a cardiac glycoside commonly used to treat heart failure and certain arrhythmias. Digoxin toxicity can occur due to its narrow therapeutic index, where the drug's therapeutic and toxic doses are close. Nausea is a common early sign of Digoxin toxicity, indicating gastrointestinal disturbances.
Option B) Dry mouth is not typically associated with Digoxin toxicity. Option C) Hypoglycemia is not a common sign of Digoxin toxicity; rather, it can cause hyperglycemia. Option D) Tinnitus is associated with toxicity of another medication class called aminoglycoside antibiotics, not Digoxin.
From an educational perspective, understanding the signs and symptoms of Digoxin toxicity is crucial for healthcare providers to ensure safe medication administration and patient care. Recognizing early signs like nausea can prompt timely intervention and prevent serious complications associated with Digoxin toxicity. It reinforces the importance of comprehensive pharmacological knowledge and vigilant assessment in clinical practice.
Option B) Dry mouth is not typically associated with Digoxin toxicity. Option C) Hypoglycemia is not a common sign of Digoxin toxicity; rather, it can cause hyperglycemia. Option D) Tinnitus is associated with toxicity of another medication class called aminoglycoside antibiotics, not Digoxin.
From an educational perspective, understanding the signs and symptoms of Digoxin toxicity is crucial for healthcare providers to ensure safe medication administration and patient care. Recognizing early signs like nausea can prompt timely intervention and prevent serious complications associated with Digoxin toxicity. It reinforces the importance of comprehensive pharmacological knowledge and vigilant assessment in clinical practice.